Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$10.32 - $12.13 $722,400 - $849,100
-70,000 Reduced 41.18%
100,000 $1.16 Million
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $1.59 Million - $1.9 Million
158,000 Added 1316.67%
170,000 $1.81 Million
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $1.84 Million - $2.21 Million
-163,000 Reduced 93.14%
12,000 $143,000
Q4 2023

Feb 14, 2024

SELL
$8.77 - $10.85 $74,545 - $92,225
-8,500 Reduced 4.63%
175,000 $1.9 Million
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $110,285 - $130,525
-11,500 Reduced 5.9%
183,500 $1.81 Million
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $247,148 - $281,946
27,400 Added 16.35%
195,000 $1.95 Million
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $813,279 - $1.08 Million
-88,400 Reduced 34.53%
167,600 $1.61 Million
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $831,888 - $1.1 Million
-95,400 Reduced 27.15%
256,000 $2.85 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $690,272 - $905,982
81,400 Added 30.15%
351,400 $2.99 Million
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $447,749 - $552,150
-45,000 Reduced 14.29%
270,000 $2.83 Million
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $1.08 Million - $1.69 Million
110,000 Added 53.66%
315,000 $3.43 Million
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $60,450 - $73,400
-5,000 Reduced 2.38%
205,000 $2.77 Million
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $662,500 - $756,500
50,000 Added 31.25%
210,000 $2.85 Million
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $389,100 - $484,499
30,000 Added 23.08%
160,000 $2.29 Million
Q1 2021

May 14, 2021

BUY
$13.59 - $18.54 $1.77 Million - $2.41 Million
130,000 New
130,000 $1.82 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $11.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.